Papers
1
Total Citations
2
H-Index
1
About
Ebru Canda is a dedicated researcher in the field of urological oncology, with a particular focus on the treatment and management of invasive bladder cancer. Her work addresses critical challenges in the clinical management of this aggressive disease, contributing to the understanding of therapeutic strategies that can improve patient outcomes. While her most-cited paper, "Therapie des invasiven Harnblasenkarzinoms" (2014), has garnered 2 citations, it serves as a foundational piece in the German-language literature on bladder cancer therapy, reflecting her commitment to disseminating knowledge within the medical community. Canda's research interests extend to exploring multidisciplinary approaches, including surgical techniques and systemic therapies, that are essential for advancing care in urological cancers. Her contributions, though modest in citation count, underscore the importance of regional and language-specific clinical research in shaping treatment paradigms. For students and researchers, Canda's work exemplifies the value of targeted, clinically relevant studies that bridge gaps in localized medical practice, offering insights into the nuanced management of invasive bladder carcinoma.
Research Focus
Key Achievements
Top Papers
- 1Therapie des invasiven Harnblasenkarzinoms2 citations · 2014